Metastatic Colorectal Cancer · Fase 2 · NCT06820463
Telisotuzumab Adizutecan, Fluorouracil, Oxaliplatin, Leucovorin
AbbVie · Abrir el resumen
Ras-mutated Metastatic Colorectal Cancer · Fase 2 · NCT07446322
Bevacizumab, FOLFIRI, Pelareorep
Oncolytics Biotech · Abrir el resumen
Colon Cancer · Fase 2 · NCT07808151
Pembrolizumab, Porustobart
Solstice Oncology, Inc. · Abrir el resumen
Cáncer colorrectal · Fase 2 · NCT07659795
VS-7375, cetuximab, panitumumab, Cetuximab + mFOLFOX6
Verastem, Inc. · Abrir el resumen
Metastatic Colorectal Cancer · Fase 2 · NCT01174121 · Artículos
Pembrolizumab (Keytruda), Fludarabine, Cyclophosphamide, Aldesleukin
National Cancer Institute (NCI) · Abrir el resumen
Metastatic Small Intestinal Adenocarcinoma · Fase 2 · NCT04205968
Fluorouracil, Irinotecan, Irinotecan Hydrochloride, Leucovorin
SWOG Cancer Research Network · Abrir el resumen
Rectal Adenocarcinoma · Fase 2 · NCT04165772 · Artículos
TSR-042 or Dostarlimab, capecitabine or 5-FU, Intensity Modulated Radiation Therapy (IMRT)
Memorial Sloan Kettering Cancer Center · Abrir el resumen
Refractory Metastatic Colorectal Cancer · Fase 2 · NCT06607458
Melphalan/HDS Followed by Consolidation Treatment with Trifluridine-tipiracil plus Bevacizumab, Trifluridine-tipiracil plus Bevacizumab Alone
Delcath Systems Inc. · Abrir el resumen
Advanced Microsatellite Stable Colorectal Cancer · Fase 2 · NCT07527858
Denikitug, Nivolumab, Bevacizumab, Trifluridine-Tipiracil
Gilead Sciences · Abrir el resumen
Advanced Colon Adenocarcinoma · Fase 2 · NCT07595874
Balstilimab, Biospecimen Collection, Botensilimab, Computed Tomography
City of Hope Medical Center · Abrir el resumen
Metastatic Colorectal Cancer (Mcrc) · Fase 2 · NCT05286814 · Artículos
Dexamethasone, PDS01ADC, Intera 3000 Hepatic Artery Infusion Pump (HAIP), Floxuridine
National Cancer Institute (NCI) · Abrir el resumen
Cáncer colorrectal · Fase 2 · NCT06992258
Fruquintinib+ Lonsurf (trifluridine and tipiracil), Fruquintinib
Criterium, Inc. · Abrir el resumen
Cáncer colorrectal · Fase 2 · NCT07023289
Telisotuzumab Adizutecan, Standard of Care
AbbVie · Abrir el resumen
Metastatic Colorectal Cancer (CRC) · Fase 2 · NCT06887218 · Artículos
Regorafenib (BAY 73-4506), 5FU/LV, Bevacizumab, Trifluridine-tipiracil
The Methodist Hospital Research Institute · Abrir el resumen
Anal Cancer · Fase 2 · NCT06493019
Pembrolizumab, Paclitaxel, Carboplatin, Radiation
Dustin Deming · Abrir el resumen
Rectal Adenocarcinoma · Fase 2 · NCT06569368
Metronidazole
M.D. Anderson Cancer Center · Abrir el resumen
Colorectal Adenocarcinoma Metastatic in the Liver · Fase 2 · NCT07082439
Pembrolizumab, Odetiglucan
Abramson Cancer Center at Penn Medicine · Abrir el resumen
Localized Colon Carcinoma · Fase 2 · NCT07140679
Biopsy Procedure, Biospecimen Collection, Colonoscopy, Computed Tomography
Emory University · Abrir el resumen
Colorectal Adenocarcinoma · Fase 2 · NCT07551596
Balstilimab, Biopsy Procedure, Biospecimen Collection, Botensilimab
National Cancer Institute (NCI) · Abrir el resumen
Advanced Colorectal Cancer · Fase 2 · NCT06369259
Defactinib, Cetuximab, Avutometinib
M.D. Anderson Cancer Center · Abrir el resumen
Cáncer colorrectal · Fase 2 · NCT07227636
Botensilimab, Balstilimab, Placebo
Memorial Sloan Kettering Cancer Center · Abrir el resumen
Metastatic Colorectal Cancer · Fase 2 · NCT05854498
Liposomal irinotecan, TAS102, Bevacizumab
University of Wisconsin, Madison · Abrir el resumen
Rectal Adenocarcinoma · Fase 2 · NCT07292298
High Rare Dose Rectal Brachytherapy Boost
University of Colorado, Denver · Abrir el resumen
Cáncer colorrectal · Fase 2 · NCT07071961
Regorafenib (CT), Lorigerlimab
M.D. Anderson Cancer Center · Abrir el resumen